Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)
Mes dernières consult.
Most popular
Delayed Quote. Delayed  - 10/20 05:35:07 pm
61.48 EUR   +2.35%
10/20 UCB FIRST NINE :  Strong 9 …
10/20 UCB : By the time you finish reading this headline another person &h..
10/17UCB SA : quaterly earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

UCB : marks World Parkinson’s Disease Day with new ‘Parkinson’s Well-Being Map™’

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/11/2012 | 07:34am CEST

• The Parkinson's Well-Being Map™ is a new visual tool to support communication of a person's Parkinson's status with their healthcare team
• 'Living with Parkinson's Disease: Insights and Inspirations' video shares personal and motivational perspectives on PD

Brussels, Belgium, 11th April 2012, 0700 CET - UCB is announcing a new initiative for World Parkinson's Disease Day 2012 that is designed to support communication around all aspects of Parkinson's Disease (PD). The Parkinson's Well-Being Map™ is a visual tool designed to help people with PD discuss their health status and well-being with their care teams. A new video 'Living with Parkinson's Disease: Insights and Inspirations' is also shared today and gives a voice to people with Parkinson's on the effects of the condition on their lives.

The Parkinson's Well-Being Map™ was developed by UCB in consultation with people living with PD and in partnership with the European Parkinson's Disease Association (EPDA), the Cure Parkinson's Trust and the Spanish Federation of Parkinson's Disease.

"The Parkinson's Well-Being Map™ translates a complex issue into an 'at-a-glance' summary of symptoms of an individual's Parkinson's. By including both movement related and underlying symptoms, it can help people talk to their healthcare team about all aspects of Parkinson's including symptoms such as sleep disturbances and mood changes, which they may not have realised could be part of their Parkinson's," said Knut-Johan Onarheim, President of the EPDA.

Designed to be simple and easy to use, the Parkinson's Well-Being Map™ should help people with Parkinson's monitor and record their symptoms over time as well as summarise their health and well-being in preparation for their consultation with their healthcare team. The Map is already available in paper format in certain countries worldwide, and will be available in further countries during 2012.

UCB is committed to supporting educational programs that inspire and encourage people living with Parkinson's Disease to achieve their personal goals and to support communication on their health and well-being with their care team. The Parkinson's Well-Being Map™ builds on 'Today I will…' an ongoing initiative from UCB which encourages people affected by Parkinson's to make motivational pledges to inspire and support others.

'Today I will…' pledges received to date include:

• "Today I will… take inspiration from other pledges, then hopefully realise I'm not alone. I thank you all."
• "Today I will… totally forget my Parkinson's when walking in the sun, the energy comes back, the winter time is over and then I really enjoy my life!"
• "Today I will… ask my patient how they are living rather than how they are moving."

"Parkinson's Disease is a complicated condition which can have a significant impact on how people live their lives. At UCB we are committed to supporting people with Parkinson's by developing resources that help them to communicate their full range of symptoms to their healthcare teams and connect with each other for motivation and inspiration," said Lode Dewulf, MD, Vice President, Global Medical Affairs, UCB.

People can show their support on World Parkinson's Disease Day by viewing 'Living with Parkinson's Disease: Insights and Inspirations' at http://www.youtube.com/user/UCB?ob=0&feature=results_main or to learn more about UCB's educational initiatives to inspire people with Parkinson's including the Parkinson's Well-Being Map™ and 'Today I will…' visit www.parkinsons-voices.eu.

For further information
Eimear O Brien, Director, Communications, UCB
T +32.2.559.9271, [email protected]

NOTES TO EDITORS

About World Parkinson's Disease Day
World Parkinson's Disease Day is marked on April 11 in commemoration of the birth of Dr. James Parkinson (1755 - 1824) who established the disease as a clinical entity.1 Activities on this day aim to raise public awareness for one of the most common progressive degenerative neurological disorders and to show support for people living with the condition.

About Parkinson's Voices ( )
Parkinson's Voices (www.parkinsons-voices.eu) is a UCB website created for people who want to know more about PD, to share experiences with those who have the condition, and to find out how different members of their healthcare team can help them. www.parkinsons-voices.eu

About Parkinson's Disease
PD is a progressive neurological condition which affects over six million people worldwide.2 It is predominantly characterised by problems with body movements, known as 'motor symotoms'.2 The classical symptoms of PD are tremor, muscular rigidity and bradykinesia including slowness and poverty of movement.3 Other underlying symptoms that are not related to movement can also occur such as pain, sleep disturbance and mood changes.2

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

References
1. European Parkinson's Disease Association Charter. 1997. Available at http://www.epda.eu.com/worldpdday/epda-charter/ Last accessed March 2012
2. European Parkinson's Disease Association - Life with Parkinson's disease: What is Parkinson's disease? Available at: http://www.parkinsonsawareness.eu.com/en/campaign-literature/what-is-parkinsons-disease/ Last accessed March 2012
3. European Parkinson's Disease Association - Life with Parkinson's disease: Symptoms Available at: http://www.parkinsonsawareness.eu. Last accessed March 2012

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on UCB
10/20 UCB FIRST NINE MONTHS INTERIM REPORT :  Strong 9 …
10/20 UCB : By the time you finish reading this headline another person …
10/17UCB SA : quaterly earnings release
10/17 UCB : Transparency notification The Capital Group Companies
10/13 UCB : Transparency notification The Capital Group Companies
09/21 UCB : Studies from UCB S.A. Reveal New Findings on Extracellular Space (Quantita..
09/15 NEW INDICATION FOR BRIVIACT® (BRIVAR : UCB’s newest antiepileptic drug &he..
09/14 UCB : New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of..
09/11 UCB : EVENITYTM (romosozumab) ARCH Study Results Published in the New England &h..
09/08 UCB : highlights latest EVENITY™ (romosozumab) research at the American So..
More news
News from SeekingAlpha
07/31 UCB's (UCBJF) CEO Jean Tellier on Q2 2017 Results - Earnings Call Transcript
07/17 FDA rejects Amgen's marketing application for osteoporosis candidate romosozu..
05/22 Amgen's and UCB's romosozumab successful in late-stage osteoporosis study but..
03/21 UCB Needs Clinical Success To Drive Upside
02/24 UCB S.A. 2016 Q4 - Results - Earnings Call Slides
Financials (€)
Sales 2017 4 337 M
EBIT 2017 971 M
Net income 2017 614 M
Debt 2017 580 M
Yield 2017 1,95%
P/E ratio 2017 18,02
P/E ratio 2018 15,53
EV / Sales 2017 2,89x
EV / Sales 2018 2,66x
Capitalization 11 958 M
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Technical analysis trends UCB
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 65,8 €
Spread / Average Target 7,0%
EPS Revisions
Managers
NameTitle
Jean-Christophe Tellier Chief Executive Officer & Executive Director
Evelyn du Monceau Chairman
Charl van Zyl Chief Operating Officer
Detlef Thielgen Chief Financial Officer & Executive Vice President
Iris Löw-Friedrich Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
UCB-0.44%14 090
JOHNSON & JOHNSON23.29%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER11.58%213 372
MERCK AND COMPANY7.88%173 214